ELISA Kit for Asymmetrical Dimethylarginine (ADMA)
CEB301GE
Product group Assays
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Asymmetrical Dimethylarginine (ADMA)
- Delivery Days Customer12
- Assay Detection Range12.35-1,000ng/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Asymmetrical Dimethylarginine (ADMA) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 4.99ng/mL
- Assay Test PrincipleThis assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Asymmetrical Dimethylarginine (ADMA) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin ...
- Assay Time2h
- CertificationResearch Use Only
- UNSPSC41116158
References
- Effect of a Low Dose of Carvedilol on Cyclophosphamide-Induced Urinary Toxicity in Rats-A Comparison with Mesna. Merwid-Lad A et al., 2021 Nov 29, Pharmaceuticals (Basel)Read more
- Non-functioning adrenal incidentalomas may increase toxic metabolites. Karahan I et al., 2022 Feb, Wien Klin WochenschrRead more
- Levels of endothelial substances in patients with newly identified hypertension compared with healthy controls. Biel V et al., 2021 Nov, Biomed Pap Med Fac Univ Palacky Olomouc Czech RepubRead more
- Multivessel analysis of progressive vascular aging in the rat: Asynchronous vulnerability among vascular territories. El Assar M et al., 2018 Jul, Mech Ageing DevRead more
- A Novel Role of Irbesartan in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats: Targeting DDAH/ADMA and EGFR/ERK Signaling. Shahin NN et al., 2018 Mar 9, Sci RepRead more
- Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA). Reddy KRK et al., 2018 Feb, AngiogenesisRead more
- Increased serum concentrations of asymmetric dimethylarginine (ADMA) in patients with early-onset coronary artery disease. Xuan C et al., 2017 Jan, Clin Chim ActaRead more
- Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study. Xuan C et al., 2016 Sep 28, Sci RepRead more
- Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans. El Assar M et al., 2016 Jun 1, J PhysiolRead more
- Dimethylarginine dimethylaminohydrolase-1 mediates inhibitory effect of interleukin-10 on angiotensin II-induced hypertensive effects in vascular smooth muscle cells of spontaneously hypertensive rats. Kim HY et al., 2016 Jan, CytokineRead more